About Us       Blog       Clients       Disclaimer       Market Basics       Partners       Quotes & News       Video       Contact Us
The QualityStocks Daily Newsletter for Monday, September 29th, 2014

The QualityStocks
Daily Stock List

graphic
graphic

Tauriga Sciences, Inc. (TAUG)

TheMicrocapNews, Greenbackers, Wallstreetlivechat, PennyStocks Forever, Stock Tips Network, Stock Analyzer, PennyStocks24, Xtremepicks, Penny Stock Rumble, and OurHotStockTips reported earlier on Tauriga Sciences, Inc. (TAUG), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

Listed on the OTCQB, Tauriga Sciences, Inc. is concentrating on generating profitable revenues by way of license agreements and the development of a proprietary technology platform in the nano-robotics space. A diversified life sciences company, Tauriga’s business model includes the acquisition of licenses, equity stakes, rights on both an exclusive and non-exclusive basis, and entire businesses. It also has its acquisition in the cannabis space. The Company previously went by the name Immunovative, Inc. It changed its corporate name to Tauriga Sciences, Inc. in March 2013.
 
Tauriga has been working to establish an international presence through partnerships and international exclusive licenses, because its’ proprietary BactoBot technology can potentially address several global water related issues. On January 28, 2014, the Company announced that it completed the acquisition of Cincinnati, Ohio based synthetic biology pioneer Pilus Energy, LLC. Pilus Energy is now a wholly-owned subsidiary of Tauriga Sciences. Pilus maintains its headquarters location in Ohio.

Pilus Energy is a developer of alternative cleantech energy platforms employing proprietary microbial solutions that creates electricity while consuming polluting molecules from wastewater. In the process, the technology generates electricity and produces economically important gases and chemicals. Pilus Energy licenses a low-cost, scalable electrogenic bioreactor platform and wastewater-to-value BactoBots. Pilus Energy will also gain additional revenues from carbon and renewable energy credits (REC).

Tauriga Sciences announced in May that it entered into its first retail distribution agreement for its new line of natural medicine products. The Company’s natural medicine product line will include non-cannabis containing candies, gums, and supplements with proprietary formulations designed to address unwanted cannabis-related effects.

Tauriga announced in July that it completed its acquisition of California-based medicinal cannabis firm Honeywood LLC. Honeywood is the formulator for Doc Green's topical cannabis cream and for other products. With this completed acquisition agreement, Honeywood will operate as a wholly-owned subsidiary of Tauriga Sciences. All future revenues and profits (losses) will be shown on Tauriga's pro forma financial statements.

This month, Tauriga Sciences announced that on September 8, 2014, via its subsidiary Pilus Energy, it received final approval for its Health and Safety Plan (H & S Plan). The approval was granted by the United States Environmental Protection Agency (EPA) and the project subcontractor Chicago Bridge & Iron (CB & I), which operates the EPA's Test & Evaluation (T & E) Facility where the next phase of the commercial pilot will take place.

This final approval, along with the already approved Quality Assurance Project Plan, will allow Tauriga to start development scale pilot testing at the EPA T& E Facility. In March, Pilus launched a five-phase commercial pilot study to customize a proprietary "wastewater to value" solution and to demonstrate feasibility of applying Pilus's synthetic biology platform to a large scale industrial sewage treatment plant. 

Tauriga Sciences, Inc. (TAUG), closed Monday's trading session at $0.019, down 7.32%, on 2,513,693 volume with 67 trades. The average volume for the last 60 days is 4,847,059 and the stock's 52-week low/high is $0.0035/$0.1075.

Petron Energy II, Inc. (PEII)

PennyStocks24, TheMicrocapNews, BullFreak, VIP Penny Stocks, StockRunway, FatCat Stocks, To Best Pennystocks, OTCEquity, PennyStockSpy, 007 Stock Chat, Winston Small Cap, and Stock Roach reported this month on Petron Energy II, Inc. (PEII), and we are highlighting the Company as well, here at the QualityStocks Daily Newsletter.

Petron Energy II, Inc., together with its subsidiaries, engages in the acquisition and development of properties for the production of crude oil and natural gas, the transportation of natural gas through its pipeline subsidiary, and well servicing through its servicing subsidiary. It develops oil and gas properties in low risk areas with years of proven production history. Petron Energy II’s subsidiaries are Petron Energy II Pipeline, Inc. and Petron Energy II Well Service, Inc.  Dallas, Texas-based Petron Energy II lists on the OTCQB.

The Company’s Petron Energy II Pipeline engages mainly in the transmission of gas and gas liquids for its wells and third party wells in the United States.  Petron Energy II Well Service engages primarily in Well Service operation for its wells, at present. It expects to begin well service operations for third party operators in the future.

Petron Energy II is centering its development efforts in Oklahoma and Texas where it presently has acreage under lease. Regarding the Texas properties, Petron earlier agreed to acquire approximately 2,800 acres in Munday, Knox County, Texas. This property consists of 48 wells. The property has 34 of 48 existing wells capable of producing commercial quantities of oil. The Company is reviewing the property for further producing zones that may be available.

Concerning the Oklahoma properties, Petron purchased a 75 percent stake in roughly 1,100 acres with 59 wells in Wagoner and Tulsa Counties, Oklahoma. It has 56 existing wells and 3 newly drilled wells. The acreage has 5 to 7 pay zones. These pay zones can produce oil, gas and/or both commodities.

Petron purchased a 75 percent equity stake in a 105 mile pipeline gas system, Petron Energy II Pipeline, Inc. The pipeline system extends from Wagoner County into Tulsa County, Oklahoma. Additionally, it purchased a 75 percent stake in a second gas pipeline system, Petron Energy II TNT, Inc. This pipeline system extends 30 miles through Wagoner, Mayes, Rogers, and Tulsa Counties, Oklahoma.

In June, Petron Energy II signed an Acquisition Agreement to purchase the Garrett Lease in Creek County, Oklahoma. Also, Petron II announced that on Friday June 27, 2014 the Texas Railroad Commission (RRC) approved its P-5 application. This essentially cleared the way for all of its Texas wells to be returned to commercial production. On July 7, 2014, the Company announced that it had returned its Texas wells back to full production.

This month, Petron Energy II reported an increasing trend in its oil production. The Company announced that it posted its largest year-to-date production month in August with 482 barrels of oil sold for the month. It has been focusing on improving its production and its monthly production has been trending higher since June.

Petron Energy II, Inc. (PEII), closed Monday's trading session at $0.0003, even for the day, on 45,397,420 volume with 113 trades. The average volume for the last 60 days is 23,396,674 and the stock's 52-week low/high is $0.0002/$0.10.

Aethlon Medical, Inc. (AEMD)

StockBlogs reported recently on Aethlon Medical, Inc. (AEMD), Streetwise Reports, BestStockChoice, and PennyStocks24 did earlier, and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

Aethlon Medical, Inc.'s mission is to create novel medical devices that address unmet medical needs in cancer, infectious disease, and other life-threatening conditions. Its Aethlon ADAPT™ System (Adaptive Dialysis-Like Affinity Platform Technology) is a revenue-stage technology platform. This system provides the foundation for a new class of therapeutics, which target the selective removal of disease enabling particles from the entire circulatory system. Aethlon Medical is based in San Diego, California.

In September 2013, Aethlon Medical announced the formal launch of Exosome Sciences, Inc. (ESI). This is its majority-owned subsidiary earlier established by Aethlon to pursue exosome-based strategies to diagnose and monitor the progression of cancer, infectious disease, and other life-threatening conditions.

The Aethlon ADAPT™ System is a medical device platform that joins single or multiple affinity drug agents with advanced plasma membrane technology. This is to create therapeutic filtration devices that selectively remove harmful particles from the entire circulatory system without the loss of essential blood components.

The Aethlon ADAPT™ product pipeline includes the Aethlon Hemopurifier® to address infectious disease and cancer. Aethlon Medical’s Aethlon Hemopurifier® is a first-in-class medical device with wide spectrum capabilities against viral pathogens. These include the human immunodeficiency virus (HIV), hepatitis C virus (HCV), and many bioterror and pandemic threats. 

Aethlon Medical also has its ELLSA™ Exosome Assay. This is an enzyme-linked lectin-specific assay that has demonstrated the ability to identify and quantify the presence of exosomes underlying the human immunodeficiency virus (HIV), tuberculosis (TB), and all forms of cancer tested to date. The Company’s pipeline also includes a medical device undergoing development under a five-year contract with Defense Advanced Research Projects Agency (DARPA) to reduce the incidence of sepsis in combat-injured soldiers (DARPA Sepsis Program). Moreover, Aethlon has its HER2osome™. It provides a therapeutic strategy to maximize the ability of the immune system and established drug therapies to combat HER2+ breast cancer.

In early September, Aethlon Medical announced that it received independent internal review board (IRB) approval to initiate human clinical studies of Hemopurifier® therapy at DaVita MedCenter Dialysis in Houston, Texas. Due to the independent IRB approval, Aethlon is now permitted to initiate the Investigational Device Exemption (IDE) approved study.

In addition, this month, Aethlon Medical and Exosome Sciences (ESI) announced that ESI researchers have developed and initially validated a lectin-based diagnostic platform. This platform is able to isolate exosome-based biomarkers underlying a wide array of oncology indications.

Last week, Aethlon Medical disclosed that the Defense Advanced Research Projects Agency (DARPA) informed the Company that it plans to exercise an option to proceed with year four of a five-year $5.9 million contract, which was awarded to Aethlon Medical on September 30, 2011 under DARPA's Dialysis-Like Therapeutics (DLT) program.

Aethlon Medical, Inc. (AEMD), closed Monday's trading session at $0.125, even for the day, on 324,766 volume with 38 trades. The average volume for the last 60 days is 138,956 and the stock's 52-week low/high is $0.1025/$0.27.

Mantra Venture Group Ltd. (MVTG)

The Green Baron and SmallCapVoice reported on Mantra Venture Group Ltd. (MVTG), and we are reporting on the Company as well, here at the QualityStocks Daily Newsletter.

OTCQB-listed Mantra Venture Group Ltd. is a clean technology incubator. It takes innovative emerging technologies and moves them towards commercialization. The Company’s mission is to develop and commercialize alternative energy technologies and services. This is to enable the sustainable consumption, production, and management of resources on residential, commercial, and industrial scales. Its subsidiary, Mantra Energy Alternatives Ltd., identifies, acquires, develops, and markets technologies related to alternative energy production, greenhouse gas emissions reduction, and resource consumption reduction.

Mantra, through Mantra Energy Alternatives, is currently advancing a state-of-the-art carbon capture and utilization technology. It is referred to as the “electro-reduction of carbon dioxide” (ERC). ERC is a form of "carbon capture and utilization" (CCU) that converts the polluting greenhouse gas carbon dioxide into useful, valuable products including formic acid and formate salts. 

Mantra is also currently developing MRFC (Mixed-Reactant Fuel Cell). The MRFC is an unconventional fuel cell. It uses a mixture of fuel and oxidant. Consequently, this significantly reduces the complexity and cost of the fuel cell system. It is ideal for portable applications. The MRFC is cheaper, lighter, and more compact than conventional fuel cell technologies.

In July, Mantra Venture Group and Mantra Energy Alternatives announced the granting of the US patent for its Mixed-Reactant Fuel Cell (MRFC) technology. US Patent No. 8,709,680 B2, titled "Mixed Reactant Flow-By Fuel Cell", is the second issued for the MRFC. The first was the British patent GB 2474202 (2012). Mantra owns the exclusive worldwide license for this technology. The technology has been patented by its owner, Professor Emeritus Colin Oloman, a key member of Mantra’s Scientific Advisory Board.

This month, the Company announced that Mantra Energy Alternatives Ltd. was accepted into the Canadian Technology Accelerator (CTA) CleanTech program for the Fall of 2014. The program accepts a few of the companies by application for each cohort. The program was established and is managed by the Consulates General of Canada in New York, New York and San Francisco, California. The CTA CleanTech program is offered annually for "up to 10 promising Canadian clean technology companies", to help speed up their growth into worldwide markets.

Furthermore, this month, Mantra and Mantra Energy Alternatives Ltd. announced the allowance of the Canadian patent "Continuous Co-Current Electrochemical Reduction of Carbon Dioxide". The patent covers Mantra's innovative ERC process. This process converts the polluting gas carbon dioxide into high value chemicals and fuels. Similar patents have been granted in China, Australia, and India.

Mantra Venture Group Ltd. (MVTG), closed Monday's trading session at $0.50, down 9.09%, on 111,223 volume with 35 trades. The average volume for the last 60 days is 55,693 and the stock's 52-week low/high is $0.0471/$0.75.

ML Capital Group, Inc. (MLCG)

SmallCapVoice, The Green Baron, MyBestStockAlerts, PennyStocks24, PennyStocksVIP, Penny Pick Insider, and Pumps and Dumps reported recently on ML Capital Group, Inc. (MLCG), and we are reporting on the Company today, here at the QualityStocks Daily Newsletter.

A full service consulting firm, ML Capital Group, Inc.’s primary business consists of producing products and providing services that support the medical marijuana industry and enhances the lives of the patients that have turned to medical marijuana/cannabis to manage their diverse ailments. The Company is the owner of the SuperStar Vapor Pen, the SuperStar Dispensaries smart phone application, and the SuperStar Medical Marijuana Recipe Book. ML Capital Group has its headquarters in Fountain Hills, Arizona. The Company’s shares trade on the OTC Bulletin Board.

ML Capital Group’s business also consists of providing consulting services to public and private companies, focusing mainly on early stage companies, small businesses and emerging growth companies, with a chief focus on serving companies in the green technology and alternative energy industries.
 
ML Capital Group announced in February of this year that it is expanding its business in the medical marijuana industry to additionally include vapor pens. It is currently producing and marketing its products and services under the SuperStar brand name. This includes vapor pens, mobile applications, and books. The focus of ML Capital Group is to sell products and services that does not include the growing, manufacture, or distribution of medical marijuana, cannabis, or cannabis by-products.

The Company previously announced its entry into the medical marijuana industry with the development of smart phone applications that connect people with an array of resources that support their needs. Additionally, ML Capital Group also found another market to pursue with vapor pens. It has trademarked the brand "SuperStar Vapor Pens." The Company is entering into the medical marijuana industry on a national scale.

This past July, ML Capital Group announced that it was launching a new product line: SuperStar Hookah Pens. Its SuperStar Hookah Pen product line will initially include disposable hookah pens in five original nicotine-free flavors of vanilla, cherry, chocolate, strawberry and grape. In addition, in July, ML Capital Group announced it received approval notification of its SuperStar Vapor Pen trademark application from the United States Patent & Trademark Office (USPTO). The trademark was published on July 15, 2014.

This month, ML Capital Group announced it will open a physical retail store to showcase its SuperStar Product line and increase sales. The retail store located at 16810 E. Ave of the Fountains, Suite 103 Fountain Hills, Arizona 85268 will open on October 1, 2014. The store will feature the SuperStar brand name products such as its vapor pens, hookah pens, accessories, its medical marijuana recipe book, clothing and apparel. The store will also sell other vendor products. 

ML Capital Group, Inc. (MLCG), closed Monday's trading session at $0.0077, up 2.67%, on 17,600 volume with 6 trades. The average volume for the last 60 days is 256,524 and the stock's 52-week low/high is $0.0058/$0.185.

AmBase Corp. (ABCP)

OTCPicks and WiseAlerts reported previously on AmBase Corp. (ABCP), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Incorporated in 1975, AmBase Corp. is a holding company that has an equity investment in a real estate development property to develop real property in New York, New York. In addition, through a wholly-owned subsidiary, the Company owns a commercial office building in Greenwich, Connecticut. AmBase’s shares trade on the OTC Markets’ OTCQB. The Company has its corporate headquarters in Greenwich, Connecticut.

Ambase’s assets currently consist chiefly of cash and cash equivalents, investment securities, an equity investment in a real estate development property, an indemnification asset, and real estate owned. The Company earns non-operating revenue consisting primarily of investment earnings on investment securities and cash equivalents.

In June of 2013, Ambase, by way of a newly formed subsidiary, purchased an equity interest in a real estate development property via a Joint Venture (JV) agreement to purchase and develop real property located at 105 through 111 West 57th Street in New York, New York (111 West 57th Property"). Ambase continues to evaluate several possible acquisitions.

The Company is engaged in the management of its assets and liabilities. This includes the contingent assets associated with its legal claims. Discussions and negotiations are continuing regarding certain of these matters.

Last month, AmBase announced a net loss of $2,097,000 or $0.05 per share and $4,052,000 or $0.10 per share, for the three months and six months ended June 30, 2014, respectively. For the three months and six months ended June 30, 2013, the Company recorded a net loss of $1,383,000 or $0.03 per share and $2,100,000 or $0.05 per share, respectively.

AmBase’s assets at June 30, 2014, totalled $94,748,000, consisting chiefly of cash and cash equivalents of $2,977,000, investment securities of $9,798,000, an equity investment in a real estate development property of $61,440,000, an indemnification asset - federal tax gross-up of $18,429,000 and real estate owned, net of $1,800,000. At June 30, 2014, AmBase’s liabilities, including an uncertain tax position reserve, totalled $39,552,000. Total stockholders' equity was $55,196,000.

AmBase Corp. (ABCP), closed Monday's trading session at $1.33, even for the day. The average volume for the last 60 days is 12,373 and the stock's 52-week low/high is $1.01/$1.45.

The Alkaline Water Company, Inc. (WTER)

OTC Markets Group and SmallCapVoice reported recently on The Alkaline Water Company, Inc. (WTER), and we choose to highlight the Company today, here at the QualityStocks Daily Newsletter.

The Alkaline Water Company, Inc. has developed an innovative, state-of-the-art, proprietary electrolysis beverage process that produces healthy alkaline water. This water is packaged and sold in 700ml, 1/2, 3 liter, as well as 1 gallon sizes under the trade name Alkaline88. Alkaline88's premier alkaline water is a pH balanced bottled alkaline drinking water enhanced with trace minerals and electrolytes. The Alkaline Water Company lists on the OTC Markets’ OTCQB and the Company has its corporate headquarters in Scottsdale, Arizona.

The design of Alkaline88 is to encourage daily consumption of Alkaline Water by way of a consumer-oriented bulk delivery system targeted at removing expensive small bottles from the distribution supply chain. Alkaline88 is produced at an 8.8 pH, intended to obtain optimum body balance. It contains trace Himalayan minerals.

The Alkaline Water Company employs an advanced Electrochemically Activated Water (ECA) system to create 8.8 pH drinking water without the use of any chemicals. The ECA process uses specialized electronic cells coated with a variety of rare earth minerals to produce scientifically engineered water.

Last week, The Alkaline Water Company announced that it introduced product distribution with Hangar 24 Craft Distribution, LLC. The Hangar 24 team is in Redlands, California. It is well known for its inventive craft brewery situated directly across the street from the Redlands Municipal Airport. It offers a first-rate regional distribution network servicing San Bernardino, Riverside, and Orange counties in California.

The Alkaline Water Company Chief Executive Officer and President, Mr. Steven Nickolas, stated, "Hangar 24 will be distributing our single serving products in the 700ml, 1/2 and 1 liter sizes. Hangar 24 is another significant Direct Store Distributor (DSD) carrying our single serving bottles. This agreement is another significant step in our Southern California expansion. We are very pleased that Hangar 24 has joined us as part of our DSD national marketing strategy."

The Alkaline Water Company, Inc. (WTER), closed Monday's trading session at $0.1145, up 4.09%, on 62,095 volume with 27 trades. The average volume for the last 60 days is 511,232 and the stock's 52-week low/high is $0.092/$0.70.

graphic

The QualityStocks
Company Corner

graphic
graphic

Sibling Group Holdings, Inc. (SIBE)

The QualityStocks Daily Newsletter would like to spotlight Sibling Group Holdings, Inc. (SIBE). Today, Sibling Group Holdings, Inc. closed trading at $0.177, even for the day, on 5,000 volume with 1 trade. The stock’s average daily volume over the past 60 days is 51,034, and its 52-week low/high is $0.031/$0.24.

Sibling Group Holdings, Inc. announced today that President David Saba will be interviewed live tomorrow by host Michael Yorba on Clear Channel Business Talk Radio's The Traders Network Show. In this exclusive 2-segment interview, Saba will discuss the company's focus on providing more effective and efficient solutions to improve student achievement while driving down overall costs. The spot will air Tuesday, September 30, 2014 on Clear Channel, at Station: DFW 1190AM, on the KFXR Show: The Traders Network, hosted by Michael Yorba at 8:00am EDT | 5:00am PDT | 7:00am CDT (U.S.), with the Live iHeart Radio Stream available at the following link: http://www.iheart.com/live/4276/?autoplay=true

Sibling Group Holdings, Inc. (SIBE) is enhancing and delivering 21st century learning with advanced technology and education management operations. Accessing funds from the public capital markets is part of the company’s unified strategy to accelerate the improvement of Pre-K, K-12 and post-secondary education around the world. Better educated children and adults, sustainable and cost effective instructional models, and reduced dependence on governmental funding are the end results.

Existing offerings include professional development for the teaching profession; educational technology, including classroom management tools; a comprehensive and flexible online curriculum; an aggregation platform for massive open online courses, and academic and skills credentialing. Investments are being made in specialized curriculum such as STEM (science, technology, engineering and math), ESL (english as a second language), SEL (social and emotional learning), and Special Ed aimed at supporting students with special needs and their teachers.

Sibling Group is acquiring various Ed-tech businesses and components with the goal of building the first complete solution for the delivery and management of educational content, and tracking educational results, in the digital media – from curriculum to course certification. The recent acquisition of Blended Schools Network (BSN), which serves over 160 school districts with 300,000 course enrollments and currently offers 212 different online courses, is a great example and has provided Sibling Group with extensive infrastructure and solid groundwork for growth in a rapidly growing industry.

IBIS Capital is forecasting fifteen-fold growth in the e-learning market over the next 10 years and has even suggested that under certain circumstances the transition to digital education may be quicker and more disruptive than ever observed in the media industry. With a strong, highly experienced management team, Sibling Group is in a unique position to continue expanding its portfolio through additional acquisitions and fundamental growth. Disclaimer

Sibling Group Holdings, Inc. Company Blog

Sibling Group Holdings, Inc. News:

Sibling Group Holdings, Inc. President David Saba, to Be Interviewed LIVE on Clear Channel Business Talk Radio -- (September 30, 2014)

Sibling's Blended Schools Network Division Offers Special Education Professional Development for All Educators

Sibling's BSN Division Launches Teacher Professional Development on Udemy Global Marketplace

Vaporin, Inc. (VAPOD)

The QualityStocks Daily Newsletter would like to spotlight Vaporin, Inc. (VAPOD). Today, Vaporin, Inc. closed trading at $2.90, down 3.65%, on 24,296 volume with 68 trades. The stock’s average daily volume over the past 60 days is 53,551, and its 52-week low/high is $2.00/$12.50.

Vaporin, Inc. announced today that it has agreed with QualityStocks to be featured in The Small Cap QualityStocks Daily Newsletter, QualityStocks Daily Blogs and Message Boards. QualityStocks, based in Scottsdale, Arizona, is a free service that collates data from hundreds of Small-Cap online Investment Newsletters into one Daily Newsletter Report. QualityStocks is dedicated to assisting emerging public companies with their investor communication efforts.

Vaporin, Inc. (VAPOD) distributes and markets vaporizers, e-liquids and e-hookah products. Leveraging a multi-pronged revenue model, the company’s growth strategy includes tapping into convenience store sales and online retail continuity programs as well as the acquisition and opening of brick and mortar retail stores.

Vaporin's flagship vapor technology offers the look, feel and taste of traditional cigarettes without any tar, tobacco, smoke and odor. Additionally, vaporizers offer a better quality experience with a more satisfying hit compared to e-cigarettes and have the ability to mix and match flavors. Due to these and other advantages, Bonnie Herzog, senior beverage and tobacco analyst at Wells Faro Securities, believes vapor consumption alone will surpass combustible cigarettes in the next decade.

The company’s vaporizing products can also be used to consume cannabis in oil, wax and dry herb form. Medical marijuana is now legalized in 23 states and the market is expected to grow by 64% this year to reach $2.34 billion in sales. Through an exclusive distribution agreement with Terra Tech Corp., Vaporin anticipates rapidly increasing the exposure of its brand in this rapidly growing market via an expanding dispensary network in California, Colorado, Washington and Oregon.

In just the past year the number of vape shops has increased more than 300% to over 30,000 stores, and the industry is projected to grow to $51 billion in 2030 by industry experts. Along with its other initiatives, Vaporin has plans to ambitiously grow their retail store model by continually acquiring existing stores as well as opening new locations. As a first mover primarily focused on this burgeoning market, the company is ideally positioned with a full line of products and e-liquids. Disclaimer

Vaporin, Inc. Company Blog

Vaporin, Inc. News:

Vaporin, Inc. Announces Engagement of QualityStocks Investor Relations Services

UPDATE - Vaporin, Inc. Continues Expansion of The Vape Store Retail Locations

Why Vaporin, Inc Should be Trading Higher

Oriens Travel and Hotel Management Corp. (OTHM)

The QualityStocks Daily Newsletter would like to spotlight Oriens Travel and Hotel Management Corp. (OTHM). Today, Oriens Travel and Hotel Management Corp. closed trading at $0.0003, up 50.00%, on 32,625,785 volume with 23 trades. The stock’s average daily volume over the past 60 days is 22,999,468, and its 52-week low/high is $0.0001/$0.0024.

Oriens Travel and Hotel Management Corp. (OTHM) is a provider of proprietary technology, marketing solutions, infrastructure and branding services to hotel operators.

The company's innovative platform functions as a powerful vehicle to help hotel operators achieve greater success in three specific areas: (i) expanded international exposure and recognition, (ii) powerful core structure, and (iii) high occupancy rates that drive increases in bottom-line profits. Oriens continuously refines its suite of proprietary solutions to deliver measurable and proven results to hotel properties. This success has been reflected in those properties operating under the Hotel PURE brand as well as with independent boutique hotel properties utilizing the company's Friendly Reservation Online (FROL) booking engine technology and internet marketing services.

Operating a successful bi-lateral business model, Oriens has four objectives:

1. To franchise the Hotel PURE brand to selected hotel properties worldwide similar to the business model currently employed by Big Brand operators such as Holiday Inn, Marriott, Sheraton and others;

2. Provide highly efficient and economical back-end booking engine technology services to independently branded boutique hotels that require a robust online presence;

3. Launch a stand-alone online hotel booking search engine primarily focused on Central America; and,

4. Expand the portfolio of Oriens-owned boutique hotels operating under the Hotel PURE brand.

The company initially began growing its operations primarily in the United States. However most recently, major opportunities in Central America began presenting themselves, giving Oriens the ability to retool its business model. Now the company is positioned to acquire, own and operate its own properties – which would be marketed under the new brand with occupancies handled by the re-launched online booking engine system.

Ultimately, Oriens intends to become a top-tier hotel brand operator and Internet booking and marketing service provider, qualifying as a preferred supplier to lending institutions. The company also intends to establish an invaluable international footprint with its online booking engine technology and marketing offerings; making that segment of its business a prime acquisition target for major online travel search and booking engine companies. Advancement toward this goal is guided by an executive management team with deep expertise in technology, banking, management, hospitality, branding and marketing, technical development and more. Disclaimer

Oriens Travel and Hotel Management Corp. Company Blog

Oriens Travel and Hotel Management Corp. News:

International Hospitality Company Oriens Announces New CEO

Oriens' Merger Set to Close

Oriens' Board Accepts Plan of Merger

Cleartronic, Inc. (CLRI)

The QualityStocks Daily Newsletter would like to spotlight Cleartronic, Inc. (CLRI). Today, Cleartronic, Inc. closed trading at $0.0899, up 79.80%, on 650 volume with 1 trade. The stock’s average daily volume over the past 60 days is 8,578, and its 52-week low/high is $0.04/$0.5499.

Consorteum Holdings, Inc. (CLRI) is a technology holding company that creates and acquires operating subsidiaries to develop, manufacture and sell products, services and integrated systems to government agencies and business enterprises.

VoiceInterop, Inc., a wholly owned subsidiary, is a provider of patented IP communication gateways and communication software. Its gateways are marketed worldwide direct to customers as well as through a network of value added resellers. VoiceInterop has also developed an interoperable communication solution for use by airports. The company markets, installs and supports this interoperability solution directly to airports. International airports currently using the VoiceInterop communication solution include Dulles, Reagan, Omaha, Cincinnati, Green Bay and West Palm Beach.

A recent license agreement provides Cleartronic with the right to market Collabria LLC’s revolutionary ReadyOp™ command, control and communication platform. ReadyOp is a web-based application that integrates multiple databases and a robust communications platform supporting day-to-day activities for planning and managing small- and large-scale events. ReadyOp is designed for fast, efficient access to information and for communication with multiple persons, groups and agencies. ReadyOp is currently being used by numerous federal, state and local government agencies and private enterprises.

Backed by a management team committed to growing its business and finding ways to create value for shareholders, Cleartronic is well-positioned to grow in a broad array of markets. The company has a solid business plan in place that maximizes available resources for accelerated growth and has proven its ability to identify strong business opportunities. Disclaimer

Cleartronic, Inc. Company Blog

Consorteum Holdings, Inc. News:

Cleartronic Announces License Agreement With Collabria LLC

Cleartronic, Inc. (CLRI) Developing 'Capitalization Benefit Plan'

Cleartronic, Inc. (CLRI) Announces Strategic Relationship With Collabria, LLC

Cannabics Pharmaceuticals, Inc. (CNBX)

The QualityStocks Daily Newsletter would like to spotlight Cannabics Pharmaceuticals, Inc. (CNBX). Today, Cannabics Pharmaceuticals, Inc. closed trading at $0.30, up 3.88%, on 14,720 volume with 11 trades. The stock’s average daily volume over the past 60 days is 11,986, and its 52-week low/high is $0.03/$1.40.

Cannabics Pharmaceuticals, Inc. (CNBX) was founded in 2012 by a team of experts in the fields of molecular biology, cancer research and pharmacology, who recognized the potential of cannabinoid-based therapies for debilitating and incurable ailments. Through the course of its research, the company’s pharmacology team has amassed valuable knowledge in the development of advanced delivery systems for active cannabinoids that provide improved treatment options for patients wishing to utilize the unique medical properties of the cannabis plant.

Leveraging this expertise and knowledge, Cannabics Pharmaceuticals has created a wide range of solutions for standardized, reproducible and easily administered medical cannabis therapies. The company’s flagship product, Cannabics SR, contains a pure concentrate of cannabinoids derived from select cannabis strains, embedded in a sophisticated formulation which provides beneficial therapeutic effects for 10-12 hours upon a single oral administration.

The excipients of the proprietary Cannabics SR formulation are all certified food-grade ingredients and are free of artificial additives or chemical substances. Cannabics’ proprietary technologies are developed in certified laboratories and are licensed to certified manufacturers and distributors with adequate licenses in their local territories. Cannabics Pharmaceuticals itself does not manufacture, distribute, dispense or possess any controlled substances, including cannabis and cannabis-based preparations.

Co-founders Dr. Zohar Koren (CEO) and Dr. Eyal Ballan (CTO) guide the company’s operations with vast experience in business and pharmaceutical development, strategic consulting, venture capital, evolutionary and environmental sciences, anti-cancer drug development and molecular biology. Under their leadership, Cannabics Pharmaceuticals continues to develop its genetic and phenotipic database to provide superior treatments for incapacitating ailments for which there is no cure. Disclaimer

Cannabics Pharmaceuticals, Inc. Company Blog

Cannabics Pharmaceuticals, Inc. News:

Cannabics Pharmaceuticals, Inc. (CNBX) Attains GMP Compliance, Prepares for First Clinical Study of Cannabics SR

Cannabics Pharmaceuticals recruits two former senior Teva Executives to its Advisory Board

Cannabics Pharmaceuticals Inc. (CNBX) Focused on Developing Cannabinoid-based Therapies

Intelligent Highway Solutions, Inc. (IHSI)

The QualityStocks Daily Newsletter would like to spotlight Intelligent Highway Solutions, Inc. (IHSI). Today, Intelligent Highway Solutions, Inc. closed trading at $0.059, up 31.11%, on 6,617 volume with 4 trades. The stock’s average daily volume over the past 60 days is 81,898, and its 52-week low/high is $0.04/$0.88.

Intelligent Highway Solutions, Inc. (IHSI) is a diversified technology-based electrical contracting company focused on the development and implementation of high and low voltage solutions across multiple platforms. Aside from years of business management and financing experience, IHSI’s executive team has more than 80 years of combined electrical background, creating the perfect backdrop and catalyst for the company’s recent entrance into the overlooked yet critical lighting segment of the billowing medical marijuana industry.

Through the development of proprietary wireless vehicle detection systems designed to make the nation's roadways more efficient, IHSI developed deep relationships with the transportation markets of local and state governments. These business relationships played a significant role in IHSI securing exclusive distribution rights to lighting systems developed by SCS Lighting Solutions, an engineering and electronics company specializing in solid state diode (SSD) lighting solutions.

The initial focus of the business relationship was for IHSI to offer SCS’s highly efficient, long-lasting lighting solutions to municipalities as a means to drastically reduce energy and maintenance costs. As a result, when the new business opportunity arrived to provide a low cost, energy efficient lighting technology for accelerating the growth of cannabis plants, IHSI already had the expertise and infrastructure needed to create a superior light for this specific purpose.

Currently estimated to generate annual sales of $1.5 billion in the U.S. alone, the medical marijuana industry is one of the world’s fastest growing markets. Leveraging a C-level team of electrical contractors backed by years of business management expertise, IHSI is positioned to cultivate sustainable growth in a key segment of the medical marijuana industry through its exclusive distribution rights to proprietary lighting systems designed to help legal cannabis growers reduce costs and improve yields. Disclaimer

Intelligent Highway Solutions, Inc. Company Blog

Intelligent Highway Solutions, Inc. News:

Intelligent Highway Solutions Announces Agreement With a Washington D.C. Based Government Relations Firm

Intelligent Highway Solutions Installs 300W Grow Light at Medical Cannabis Growing Facility to Enhance Greater Yields

Intelligent Highway Solutions Announces Successful Test of Cannabis Lights and Additional Testing to Produce Greater Yields With New Prototype of Grow Light

Ecrypt Technologies, Inc. (ECRY)

The QualityStocks Daily Newsletter would like to spotlight Ecrypt Technologies, Inc. (ECRY). Today, Ecrypt Technologies, Inc. closed trading at $0.119, up 1.71%, on 11,200 volume with 4 trades. The stock’s average daily volume over the past 60 days is 6,582 and its 52-week low/high is $0.09/$0.179.

Ecrypt Technologies, Inc. (ECRY) is an emerging provider of military-strength data security solutions for enterprise, government, and military. The company empowers organizations with the freedom to communicate and collaborate without risk of liability, reputation damage, competitive threat, and other negative outcomes. Ecrypt is the trusted first choice for those looking to keep their communications confidential.

Today’s businesses struggle to guard against the increasing number of dangers as a result of complicated networks built with many different components that are often individually patched to address new threats, while neglecting to close security gaps in traditional solutions. On average, data breaches and subsequent fines and litigation cost a US business $534 million every year, the highest in the world according to the Ponemon Institute.

The flagship Ecrypt solution is an integrated email and encryption server that can be quickly deployed to fortify the security of corporate communication, including attachments and mobile devices, against data breaches while eliminating phishing threats, malware infections, and spam. By using Ecrypt’s paradigm-shifting technology, companies alleviate the need for separate encryption servers with their associated bloated administration and multiple points of weakness.

Ecrypt is well positioned to benefit from increasingly demanding data confidentiality regulations such as the Health Insurance Portability and Accountability Act (HIPAA), the Federal Information Security Management Act (FISMA), and Gramm-Leach-Bliley Act (GLBA). As a result of extensive market research and working directly with organizations in multi-billion dollar industries, the company fully understands the business community’s need to maintain confidentiality, prevent data breaches, comply with government regulations, and mitigate litigation risks. Disclaimer

Ecrypt Technologies, Inc. Blog

Ecrypt Technologies, Inc. News:

Ecrypt Technologies Inc.'s Chief Executive Officer, Dr. Thomas A. Cellucci, is the First American Elected to EECSA's Board

Safe America Appoints Ecrypt CEO to Head Drive

Ecrypt Technologies and Cicada Security Technology Enter into a Marketing Alliance

graphic

Rate Us
Tell us how we're doing!
Click here to begin your review.

Today's Top 3
Investment Newsletters

graphic

1.

Real Pennies
(PUDA)

2.

TopPennyStockMovers
(OREO)

3.

Wall Street Resources
(SIMH)

graphic
By The Numbers Charts
QualitystockTwits

The QualityStocks Public Company Sponsor News

Featured Sponsor

Daily Sponsors
















 

The QualityStocks By The Numbers Report

Click the chart below to see the full report

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market
each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge"
based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.

 

About Us     Archives     Blog     Clients     Disclaimer     Market Basics    Partners      Quotes & News     Video     Contact Us

twitter icon facebook icon

QualityStocks Logo

Copyright © 2006 - 2012. QualityStocks 3370 N. Hayden Rd., Suite 123-591, Scottsdale, AZ 85251